03Apr 2022
Incidence and Clinical Features of Pneumomediastinum and Pneumothorax in COVID-19 Pneumonia

Incidence and Clinical Features of Pneumomediastinum and Pneumothorax in COVID-19 Pneumonia

Pneumothorax (PTX) and pneumomediastinum (PM), collectively termed here “air leak”, are now well-described complications of severe COVID-19 pneumonia across several case series. The incidence is approximately 1% but is not definitively known. The main objective is to report the incidence and describe the demographic features, risk factors and outcomes of patients with air leak as a complication of COVID-19. Despite the global vaccination programme, patients continue to develop severe COVID-19 disease and may require respiratory support. This study demonstrates the importance of identifying that deterioration in such patients may be resultant from PTX or PM, particularly in asthmatics and those managed with positive pressure ventilation.

  • #critical care

Like

Save

Share